Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K
The Unfolded Protein Response01:37

The Unfolded Protein Response

4.9K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.9K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

4.7K
GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.7K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

7.4K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.4K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

65
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
65

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ligand preference of LRP1 is regulated by O-glycans.

Science advances·2026
Same author

Glial multicellular programs reveal distinct patient stratification in Parkinson's disease.

Research square·2026
Same author

Dynamic conformational ensembles of soluble Tau encode neuronal toxicity prior to aggregation.

bioRxiv : the preprint server for biology·2026
Same author

Proteomic remodelling of the neurofibrillary tangle from "PART" to advanced Alzheimer's disease.

Research square·2026
Same author

Tau biology, biomarkers, and therapeutics.

Alzheimer's & dementia (New York, N. Y.)·2025
Same author

Pseudo-Rendering for Resolution and Topology-Invariant Cortical Parcellation.

Machine learning in medical imaging. MLMI (Workshop)·2025
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Related Experiment Video

Updated: Aug 21, 2025

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.9K

All the Tau We Cannot See.

Bradley Hyman1

  • 1Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, USA;

Annual Review of Medicine
|November 15, 2022
PubMed
Summary
This summary is machine-generated.

This review explores the role of soluble tau protein aggregates, often unseen, in driving Alzheimer's disease (AD) neurodegeneration. These findings suggest a new focus for understanding and potentially treating AD pathogenesis.

Keywords:
Alzheimerbiomarkerneurofibrillary tangletautherapeutics

More Related Videos

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

8.6K
Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
12:31

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Published on: December 8, 2015

15.1K

Related Experiment Videos

Last Updated: Aug 21, 2025

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.9K
Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

8.6K
Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
12:31

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Published on: December 8, 2015

15.1K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Alzheimer's disease (AD) is characterized by brain aggregates: neurofibrillary tangles (tau protein) and senile plaques (amyloid-beta).
  • Research has established the bioactivity of smaller amyloid-beta oligomers.
  • The role of soluble, nonfibrillar tau species in AD pathogenesis remains less understood.

Purpose of the Study:

  • To review the evidence for soluble, nonfibrillar tau as a primary driver of neurodegeneration in Alzheimer's disease.
  • To highlight the potential significance of these "unseen" tau forms in AD pathology.

Main Methods:

  • Literature review of studies investigating tau protein aggregation and its role in neurodegenerative diseases.
  • Analysis of research focusing on soluble tau oligomers and their potential bioactivity.
  • Synthesis of findings related to tau's contribution to neurodegeneration in Alzheimer's disease.

Main Results:

  • Soluble, nonfibrillar forms of tau may be bioactive and contribute significantly to neurodegeneration.
  • These "unseen" tau species represent a critical, yet understudied, aspect of Alzheimer's disease.
  • The aggregation process of tau protein is central to its neurotoxic effects.

Conclusions:

  • Soluble tau species represent a dominant, potentially overlooked, driver of neurodegeneration in Alzheimer's disease.
  • Further investigation into these nonfibrillar tau forms is crucial for understanding AD and developing novel therapeutics.